DALACIN T Topical solution Ref.[6727] Active ingredients: Clindamycin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Pfizer Limited, Ramsgate Road, Sandwich Kent, CT13 9NJ, United Kingdom

Therapeutic indications

Dalacin T Topical Solution is indicated in the treatment of acne vulgaris.

Posology and method of administration

Apply a thin film of Dalacin T Topical Solution twice daily to the affected area.

Shake well before use.

Overdose

Topically applied clindamycin can be absorbed in sufficient amounts to produce systemic effects.

In the event of overdosage, general symptomatic and supportive measures are indicated as required.

Shelf life

24 months.

Special precautions for storage

Do not store above 25°C.

Nature and contents of container

Bottle: White high density polyethylene bottle containing 30 ml, 50 ml or 60 ml.

Cap: Prolypropylene, linerless screw caps or Polypropylene screw caps lined with laminated films consisting of polyethylene, polyvinylidene chloride (PVdc) and polyethylene.

Applicator: Low-density polyethylene applicator made by Dab-O-Matic.

Not all pack sizes may be marketed.

Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.